PainReform Ltd
NASDAQ:PRFX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
PainReform Ltd
NASDAQ:PRFX
|
IL |
|
Analog Devices Inc
NASDAQ:ADI
|
US |
|
H
|
HALEON PLC
NYSE:HLN
|
UK |
|
Talbros Engineering Ltd
BSE:538987
|
IN |
|
E
|
Equites Property Fund Ltd
JSE:EQU
|
ZA |
|
Aya Gold & Silver Inc
TSX:AYA
|
CA |
|
Summit Therapeutics Inc
NASDAQ:SMMT
|
US |
|
H.U. Group Holdings Inc
TSE:4544
|
JP |
|
Evercore Inc
NYSE:EVR
|
US |
|
W
|
Wal Mart de Mexico SAB de CV
SWB:4GNB
|
MX |
|
T
|
Tay Ninh Tourist - Trading JSC
VN:TTT
|
VN |
|
M
|
Motus Holdings Ltd
JSE:MTH
|
ZA |
|
Hyzon Motors Inc
NASDAQ:HYZN
|
US |
|
T
|
Tatneft' PAO
MOEX:TATNP
|
RU |
|
Intra Energy Corporation Ltd
ASX:IEC
|
AU |
|
Lions Gate Entertainment Corp
NYSE:LGF.A
|
US |
|
Y
|
Yamae Group Holdings Co Ltd
TSE:7130
|
JP |
|
Novorossiyskiy Morskoy Torgovyi Port PAO
MOEX:NMTP
|
RU |
|
S
|
SNTEnergy Co Ltd
KRX:100840
|
KR |
|
Cybergun SA
PAR:ALCYB
|
FR |
|
Shagrir Group Vehicle Services Ltd
OTC:SRRPF
|
IL |
|
Jiangsu Libert Inc
SSE:605167
|
CN |
|
Topchoice Medical Co Inc
SSE:600763
|
CN |
|
B
|
Berry Global Group Inc
SWB:BP0
|
US |
Multiples-Based Value
There is not enough data to reliably calculate the multiples-based value of PRFX.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Multiples Across Competitors
PRFX Competitors Multiples
PainReform Ltd Competitors
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| IL |
|
PainReform Ltd
NASDAQ:PRFX
|
1.6m USD | 0 | -0.1 | 0.1 | 0.1 | |
| US |
|
Eli Lilly and Co
NYSE:LLY
|
829.8B USD | 12.7 | 40.2 | 27.2 | 29 | |
| US |
|
Johnson & Johnson
NYSE:JNJ
|
579B USD | 6.1 | 21.6 | 15 | 18.4 | |
| CH |
|
Roche Holding AG
SIX:ROG
|
248.4B CHF | 4 | 19.3 | 11.5 | 12.9 | |
| US |
|
Merck & Co Inc
NYSE:MRK
|
296B USD | 4.6 | 16.2 | 10 | 12.2 | |
| CH |
|
Novartis AG
SIX:NOVN
|
229.3B CHF | 5.2 | 21.1 | 13 | 16.8 | |
| UK |
|
AstraZeneca PLC
LSE:AZN
|
214.5B GBP | 5.1 | 29.1 | 16.1 | 22.7 | |
| IE |
E
|
Endo International PLC
LSE:0Y5F
|
237.1B USD | 102.3 | -81.1 | 375.3 | 941.3 | |
| DK |
|
Novo Nordisk A/S
CSE:NOVO B
|
1T DKK | 3.3 | 9.8 | 7.3 | 8.6 | |
| US |
|
Pfizer Inc
NYSE:PFE
|
153.7B USD | 2.5 | 19.8 | 7.6 | 10.2 | |
| US |
|
Bristol-Myers Squibb Co
NYSE:BMY
|
117.8B USD | 2.4 | 16.7 | 7.1 | 8.7 |